Medico Remedies Limited

Company Profile

Medico Remedies Limited had its IPO on under the ticker symbol MEDICO.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Medico Remedies Limited has a staff strength of 150 employees.

Stock update

Shares of Medico Remedies Limited opened at ₹74.44 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹71.44 - ₹74.9, and closed at ₹74.69.

This is a -0.67% slip from the previous day's closing price.

A total volume of 13,057 shares were traded at the close of the day’s session.

In the last one week, shares of Medico Remedies Limited have slipped by -5.28%.

Medico Remedies Limited's Key Ratios

Medico Remedies Limited has a market cap of ₹6.53 billion, indicating a price to book ratio of 13.5491 and a price to sales ratio of 4.0536.

In the last 12-months Medico Remedies Limited’s revenue was ₹1.39 billion with a gross profit of ₹202.85 million and an EBITDA of ₹117.79 million. The EBITDA ratio measures Medico Remedies Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Medico Remedies Limited’s operating margin was 6.79% while its return on assets stood at 5.23% with a return of equity of 18.01%.

In Q2, Medico Remedies Limited’s quarterly earnings growth was a positive 263.6% while revenue growth was a negative 5%.

Medico Remedies Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

79.4646

PEG

Its diluted EPS in the last 12-months stands at ₹0.99 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Medico Remedies Limited’s profitability.

Medico Remedies Limited stock is trading at a EV to sales ratio of 4.1382 and a EV to EBITDA ratio of 48.6812. Its price to sales ratio in the trailing 12-months stood at 4.0536.

Medico Remedies Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹874.48 million

Total Liabilities

₹415.23 million

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

Medico Remedies Limited ended 2024 with ₹874.48 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹874.48 million while shareholder equity stood at ₹438.43 million.

Medico Remedies Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹415.23 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹9.11 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹2.47 million.

Medico Remedies Limited’s total current assets stands at ₹645.39 million while long-term investments were ₹0 and short-term investments were ₹12.84 million. Its net receivables were ₹360.95 million compared to accounts payable of ₹309.86 million and inventory worth ₹196.99 million.

In 2024, Medico Remedies Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Medico Remedies Limited paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹74.69

52-Week High

₹100.79

52-Week Low

₹20.04

Analyst Target Price

₹

Medico Remedies Limited stock is currently trading at ₹74.69 per share. It touched a 52-week high of ₹100.79 and a 52-week low of ₹100.79. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹77.8 and 200-day moving average was ₹74.24 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 8504.6% of the company’s stock are held by insiders while 177.5% are held by institutions.